
Innovation1 Biotech Inc.
IVBTOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4494
P/E Ratio—
52W High$0.005
52W Low$0.0002
Innovation1 Biotech Inc.(IVBT)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · IVBT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2023-08 | 2022-08 | 2021-08 | 2020-08 | 2019-08 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | 53.86% | -150.97% | -63.21% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | -791.21% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.04B) | $0.00B | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.01B) | ($0.04B) | $0.00B | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | -214.52% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.70 | $-2.73 | $5.53 | $-8.59 | $-0.39 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.01B) | ($0.04B) | $0.00B | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | -212.00% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解Innovation1 Biotech Inc.
关于Innovation1 Biotech Inc.(IVBT)损益表
Innovation1 Biotech Inc.(IVBT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年,IVBT实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.01B)(净利率—)。
常见问题
IVBT · 4 问Innovation1 Biotech Inc.(IVBT)2023财年营收为$0.00B,同比down—%。
IVBT revenueIVBT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08